![]() |
![]() |
![]() |
|||||
|
|
|
||||||
|
|
|||||||
|
|
|
||||||
|
Application for Commercialization Pre-seed Award and Security Agreement D-Deal Award and Security Agreement
Diabetica Solutions, Inc.
Halsa Pharmaceuticals, Inc.
MicroTransponder
OrthoAccel |
|
||||||
|
The Texas Life Science Center for Innovation and Commercialization (Texas Life Science Center, TLSCIC, TLSC) was formed to provide a central resource for the evaluation and commercialization of early stage life science companies in Texas, through the Texas Emerging Technology Fund (ETF). The ETF was originally established as a $200 million fund by the State of Texas to facilitate gap funding for technology ventures. Our advisory board consists of life science leaders from across the state, with backgrounds ranging from academia, technology transfer, industry, and venture capital. Emerging life science companies in the State of Texas can take advantage of the TLSC’s resources and expertise as they move their products through the development process.
|
|||||||
|
Texas Life Science Center P.O. Box 218749 Houston, Texas 77218 Tel: 281-857-9028 email: anat@tlscic.org sitemap | privacy policy |
|||||||
|
|
|
|
|
|
|
|
|
| |||||||